Revenio Group Oyj (LON:0KFH)
20.82
-1.88 (-8.29%)
Jan 21, 2026, 4:37 PM GMT
Revenio Group Oyj Market Cap
Revenio Group Oyj has a market cap or net worth of 424.1 million as of February 12, 2026. Its market cap has decreased by -36.86% in one year.
Market Cap
424.10M
Enterprise Value
411.99M
Revenue
95.87M
Ranking
n/a
PE Ratio
27.94
Stock Price
20.82
Market Cap Chart
Since October 1, 2001, Revenio Group Oyj's market cap has increased from 8.52M to 424.10M, an increase of 4,878.93%. That is a compound annual growth rate of 17.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 416.89M | -19.87% |
| Dec 30, 2025 | 520.28M | -11.24% |
| Dec 30, 2024 | 586.14M | -6.48% |
| Dec 29, 2023 | 626.76M | -31.13% |
| Dec 30, 2022 | 910.05M | -26.48% |
| Dec 30, 2021 | 1.24B | 2.64% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 229.82B |
| GSK plc | 86.28B |
| Haleon | 36.19B |
| Smith & Nephew | 10.90B |
| Allergy Therapeutics | 669.42M |
| Craneware | 520.81M |
| Advanced Medical Solutions Group | 466.09M |
| PureTech Health | 311.77M |